Trials / Completed
CompletedNCT02485600
Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with Duodopa (levodopa/carbidopa intestinal gel).
Conditions
Timeline
- Start date
- 2015-10-19
- Primary completion
- 2020-02-26
- Completion
- 2020-02-26
- First posted
- 2015-06-30
- Last updated
- 2021-06-25
Locations
13 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02485600. Inclusion in this directory is not an endorsement.